• Home
  • Resources
  • About
  • Agenda
  • Symposium
  • Login
  • Subscrib
  • Home
  • About
  • Resources
  • Replay
  • Symposium
  • Profile
    • Log out
  • Sign in
    • Subscrib

Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?

By Adminis
July 22, 2024
Willy Vangu
nuclear medicine, Johannesburg, South Africa
READ ARTICLE

As the BCU 2024 co-president, what's your goal for next edition of the congress end of January 2025?

By Adminis
July 22, 2024
Willy Vangu
nuclear medicine, Johannesburg, South Africa
READ ARTICLE

What's the prognostic value of PET scan imaging as a predictive tool for ER + breast cancer patients?

By Adminis
July 22, 2024
Willy Vangu
nuclear medicine, Johannesburg, South Africa
READ ARTICLE

What about the place of radiotherapy after neo adjuvent systemic therapy, can you comment the B51 trial?

By Adminis
July 22, 2024
Yazid BELKACEMI
radiotherapist, Créteil, France
READ ARTICLE
  • «
  • ‹
  • 23
  • 24
  • 25
  • 26
  • 27
  • ›
  • »

Copyright © 2026 - BCU

  • Privacy Policy
  • Mentions légales
  • Contact

Our website uses cookies to provide you the best experience. However, by continuing to use our website, you agree to our use of cookies. For more information, read our Cookie Policy.